Peloton refuses to recall its Tread+ treadmill after 39 accidents. Its stock is tumbling

New York (CNN Business)Peloton shares fell more than 7% Monday following an "urgent warning" from the United States government telling owners of the company's Tread+ to stop using the machine.

On Saturday, the Consumer Product Safety Commission said it has become aware of 39 accidents involving the $4,295 treadmill, including "multiple reports of children becoming...

Peloton refuses to recall its Tread+ treadmill after 39 accidents. Its stock is tumbling Continue reading…

FDA designates recall of abdominal stent graft system as class 1

The FDA has designated Endologix’ recall of an abdominal stent graft system as a class 1 recall, the most serious kind. The recall affects 5,403 devices (Ovation iX Abdominal Stent Graft Systems) manufactured and distributed in the U.S. since 2015, according to a safety alert from the agency. Read More

Boeing’s 737 crisis deepens as production stops for first time in two decades

Boeing Co said on Monday it would suspend production of its best-selling 737 MAX jetliner in January, its biggest assembly-line halt in more than 20 years, as fallout from two fatal crashes of the now-grounded aircraft drags into 2020.

Boeing, which builds the 737 south of Seattle, said it would not lay off any of...

Boeing’s 737 crisis deepens as production stops for first time in two decades Continue reading…

More blood pressure medicines recalled over possible cancer-causing impurity

A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in more batches of the drug, federal health officials said.

Three additional lots of losartan potassium tablets and two additional lots of losartan potassium/hydrochlorothiazide tablets were under recall, the U.S. Food...

More blood pressure medicines recalled over possible cancer-causing impurity Continue reading…

Cancer worries halt shipments of generic Zantac

A division of Swiss pharmaceutical maker Novartis is halting distribution of generic Zantac pills over concerns about an ingredient possibly linked to cancer.

Novartis-owned Sandoz has issued a "precautionary distribution stop" of all medicines containing ranitidine, an antacid and antihistamine used to block stomach acid.

The stop "in all our markets will remain in place" until...

Cancer worries halt shipments of generic Zantac Continue reading…

FDA orders manufacturers to halt sales of vaginal mesh used in many pelvic procedures

The Food and Drug Administration on Tuesday ordered manufacturers of surgical mesh used for repairing a condition called pelvic organ prolapse to immediately stop selling their products, the latest turn in a years-long battle over the safety of the implants.

The agency said the companies, Boston Scientific and Coloplast, had not demonstrated a “reasonable assurance”...

FDA orders manufacturers to halt sales of vaginal mesh used in many pelvic procedures Continue reading…

Feds continue to monitor Medtronic plant in Puerto Rico linked to recall

Investigators continue to probe a Medtronic plant that manufactured a small number of implantable defibrillators with a potentially serious problem, warning letters released last week by the Food and Drug Administration show.

The manufacturing problems at the plant in Juncos, Puerto Rico, that led to the recall happened in the months after Hurricane Maria's devastating...

Feds continue to monitor Medtronic plant in Puerto Rico linked to recall Continue reading…

Federal jury in Denver awards $383.5 million in wrongful death lawsuits against DaVita

A federal jury in Denver on Wednesday returned a verdict against dialysis giant DaVita, awarding $383.5 million in wrongful death lawsuits brought by the families of three patients who died of cardiac arrest after treatments at clinics.

DaVita staff treated the patients with GranuFlo, a product the Denver-based dialysis company knew could cause toxic pH...

Federal jury in Denver awards $383.5 million in wrongful death lawsuits against DaVita Continue reading…

Detroit 3 to get $182M from Takata for faulty air bags

Washington — Detroit automakers will receive $182.3 million from the restitution fund the former Takata Corp. established as part of its guilty plea for producing millions of defective air-bag inflators that can explode with deadly force.

The United States District Court in the Eastern District Of Michigan said Tuesday that General Motors Co. will receive...

Detroit 3 to get $182M from Takata for faulty air bags Continue reading…